CD79B and acute lymphoblastic leukemia: Exemplarily, in pro-B-ALL, an upregulation of CD79B in DEX exposed RS4;11 cells was observed, and the combined drug incubation DEX + IDEL suppresses this effect without neutralizing it completely.